Exploring Racial Disparities in Awareness and Perceptions of Oncology Clinical Trials: Cross-Sectional Analysis of Baseline Data From the mychoice Study
- PMID: 39348891
- PMCID: PMC11474127
- DOI: 10.2196/56048
Exploring Racial Disparities in Awareness and Perceptions of Oncology Clinical Trials: Cross-Sectional Analysis of Baseline Data From the mychoice Study
Abstract
Background: Black/African American adults are underrepresented in oncology clinical trials in the United States, despite efforts at narrowing this disparity.
Objective: This study aims to explore differences in how Black/African American oncology patients perceive clinical trials to improve support for the clinical trial participation decision-making process.
Methods: As part of a larger randomized controlled trial, a total of 244 adult oncology patients receiving active treatment or follow-up care completed a cross-sectional baseline survey on sociodemographic characteristics, clinical trial knowledge, health literacy, perceptions of cancer clinical trials, patient activation, patient advocacy, health care self-efficacy, decisional conflict, and clinical trial intentions. Self-reported race was dichotomized into Black/African American and non-Black/African American. As appropriate, 2-tailed t tests and chi-square tests of independence were used to examine differences between groups.
Results: Black/African American participants had lower clinical trial knowledge (P=.006), lower health literacy (P<.001), and more medical mistrust (all P values <.05) than non-Black/African American participants. While intentions to participate in a clinical trial, if offered, did not vary between Black/African American and non-Black/African American participants, Black/African American participants indicated lower awareness of clinical trials, fewer benefits of clinical trials, and more uncertainty around clinical trial decision-making (all P values <.05). There were no differences for other variables.
Conclusions: Despite no significant differences in intent to participate in a clinical trial if offered and high overall trust in individual health care providers among both groups, beliefs persist about barriers to and benefits of clinical trial participation among Black/African American patients. Findings highlight specific ways that education and resources about clinical trials could be tailored to better suit the informational and decision-making needs and preferences of Black/African American oncology patients.
Keywords: cancer; decision-making; medical mistrust; oncology clinical trial; racial disparity.
©Ariel Hoadley, Linda Fleisher, Cassidy Kenny, Patrick JA Kelly, Xinrui Ma, Jingwei Wu, Carmen Guerra, Amy E Leader, Mohammed Alhajji, Paul D’Avanzo, Zoe Landau, Sarah Bauerle Bass. Originally published in JMIR Cancer (https://cancer.jmir.org), 30.09.2024.
Conflict of interest statement
Conflicts of Interest: None declared.
Similar articles
-
Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community-engaged development and pilot testing of a digital intervention.Cancer. 2024 Oct 15;130 Suppl 20(Suppl 20):3561-3577. doi: 10.1002/cncr.35049. Epub 2023 Oct 13. Cancer. 2024. PMID: 37837177 Free PMC article.
-
Cancer clinical trial participation: a qualitative study of Black/African American communities' and patient/survivors' recommendations.JNCI Cancer Spectr. 2025 Jan 3;9(1):pkae119. doi: 10.1093/jncics/pkae119. JNCI Cancer Spectr. 2025. PMID: 39585656 Free PMC article.
-
The role of health literacy on African American and Hispanic/Latino perspectives on cancer clinical trials.J Cancer Educ. 2012 Jun;27(2):299-305. doi: 10.1007/s13187-011-0300-5. J Cancer Educ. 2012. PMID: 22203466 Free PMC article.
-
Racial disparities in Black men with prostate cancer: A literature review.Cancer. 2022 Nov 1;128(21):3787-3795. doi: 10.1002/cncr.34433. Epub 2022 Sep 6. Cancer. 2022. PMID: 36066378 Free PMC article. Review.
-
Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.JAMA Netw Open. 2021 Feb 1;4(2):e2037640. doi: 10.1001/jamanetworkopen.2020.37640. JAMA Netw Open. 2021. PMID: 33606033 Free PMC article. Review.
References
-
- Baquet CR, Henderson K, Commiskey P, Morrow JN. Clinical trials: the art of enrollment. Semin Oncol Nurs. 2008 Nov;24(4):262–9. doi: 10.1016/j.soncn.2008.08.006. https://europepmc.org/abstract/MED/19000600 S0749-2081(08)00060-0 - DOI - PMC - PubMed
-
- Unger JM, Cook E, Tai E, Bleyer A. The role of clinical trial participation in cancer research: barriers, evidence, and strategies. Am Soc Clin Oncol Educ Book. 2016;35:185–98. doi: 10.1200/EDBK_156686. https://ascopubs.org/doi/10.1200/EDBK_156686?url_ver=Z39.88-2003&rfr_id=... 156686 - DOI - DOI - PMC - PubMed
-
- Cancer facts and figures for African American/Black people 2022-2024. American Cancer Society. 2022. [2024-04-28]. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-... .
-
- Aldrighetti CM, Niemierko A, Van Allen E, Willers H, Kamran SC. Racial and ethnic disparities among participants in precision oncology clinical studies. JAMA Netw Open. 2021 Nov 01;4(11):e2133205. doi: 10.1001/jamanetworkopen.2021.33205. https://europepmc.org/abstract/MED/34748007 2785786 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials